ArticleBlood advances2026

Real-world comparative effectiveness of Bruton tyrosine kinase inhibitors in relapsed/refractory mantle cell lymphoma.

Tycel Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.